The Change of Cytokines and Gut Microbiome in Preterm Infants for Bronchopulmonary Dysplasia

Background Bronchopulmonary dysplasia (BPD) is a devastating form of chronic lung disease that develops in preterm infants. BPD is speculated to arise from abnormal inflammatory responses, which is related to the composition of commensal microbiota, leading us to hypothesize that BPD susceptibility could be influenced by gut microbiota through inflammatory responses. This study is aimed to detect cytokines and the differences in fecal gut microbial composition in the BPD patients. Methods Between June 2018 and June 2020, preterm infants born at gestational age ≤30 weeks were recruited. The clinical data of infant characteristics were collected. On days 3–7 and 14–28 after birth, fresh stool samples and serum were collected. The gut microbiota composition between the BPD group and controls was detected by 16S rRNA sequencing. On days 3–7 and days 14–28, ten cytokines including IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, IFN-γ, and TNF-α were detected in the serum. Results This study enrolled 38 preterm infants; the number of preterm infants in the BPD group and control group was, respectively, 18 and 20. The gestational age (27.4 ± 1.5 weeks vs. 29.5 ± 0.9 weeks, p = 0.000) and birth weight (971 ± 240 g vs. 1262 ± 335 g, p = 0.000) of the BPD group were lower than those of the control group. The present study found that the BPD group had high levels of IL-1β, IL-4, IL-6, IL-8, and TNF-α, whereas IL-10 was decreased. The Shannon diversity index of the BPD group was lower. The relative abundances of Proteobacteria in BPD group increased significantly from days 3–7 to days 14–28, while the Firmicutes was decreased. On days 14–28, the relative abundances of Proteobacteria in BPD group were significantly higher than those in the control group, while the Firmicutes was lower. Conclusion Bronchopulmonary dysplasia could be influenced by gut microbiota through inflammatory responses. More studies are needed to explore the imbalance of cytokines and microbiome in BPD infants and whether it could be reversed by probiotics. This study provided a novel perspective for treating BPD.

[1]  Jingjing Jiang,et al.  Cytokines and Exhaled Nitric Oxide Are Risk Factors in Preterm Infants for Bronchopulmonary Dysplasia , 2021, BioMed research international.

[2]  J. Kaempf,et al.  Prolonged tracheal intubation and the association between patent ductus arteriosus and bronchopulmonary dysplasia: a secondary analysis of the PDA-TOLERATE trial. , 2020, The Journal of pediatrics.

[3]  Kejian Wang,et al.  Beneficial Effects of Probiotic Treatment on Gut Microbiota in Very Low Birth Weight Infants , 2019, Gastroenterology research and practice.

[4]  M. Kemp,et al.  Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep. , 2019, American journal of physiology. Lung cellular and molecular physiology.

[5]  J. Pillow,et al.  Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies. , 2019, Paediatric respiratory reviews.

[6]  F. Iavarone,et al.  Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and Proteomics , 2019, Front. Pediatr..

[7]  M. Han,et al.  Bifidobacterium longum IM55 and Lactobacillus plantarum IM76 alleviate allergic rhinitis in mice by restoring Th2/Treg imbalance and gut microbiota disturbance. , 2019, Beneficial microbes.

[8]  R. Savani.  Modulators of inflammation in Bronchopulmonary Dysplasia. , 2018, Seminars in perinatology.

[9]  W. D. de Vos,et al.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota , 2017, Microbiology and Molecular Biology Reviews.

[10]  A. Gasbarrini,et al.  Proteobacteria: A Common Factor in Human Diseases , 2017, BioMed research international.

[11]  J. Pruszynski,et al.  Antibiotic Exposure and Risk for Death or Bronchopulmonary Dysplasia in Very Low Birth Weight Infants , 2017, The Journal of pediatrics.

[12]  N. Ambalavanan,et al.  Cellular and humoral biomarkers of Bronchopulmonary Dysplasia. , 2017, Early human development.

[13]  P. Hugenholtz,et al.  Emerging pathogenic links between microbiota and the gut–lung axis , 2016, Nature Reviews Microbiology.

[14]  G. Weinstock,et al.  Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study , 2016, The Lancet.

[15]  Na-Ri Shin,et al.  Proteobacteria: microbial signature of dysbiosis in gut microbiota. , 2015, Trends in biotechnology.

[16]  A. Hamvas,et al.  Lungs, Microbes and the Developing Neonate , 2015, Neonatology.

[17]  V. Bhandari,et al.  The Human Neonatal Gut Microbiome: A Brief Review , 2015, Front. Pediatr..

[18]  J. Versalovic,et al.  The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia , 2014, Pediatric Research.

[19]  V. Bhandari.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. , 2014, Birth defects research. Part A, Clinical and molecular teratology.

[20]  H. Guimarães,et al.  Cord Blood Levels of IL-6, IL-8 and IL-10 May Be Early Predictors of Bronchopulmonary Dysplasia in Preterm Newborns Small for Gestational Age , 2012, Disease markers.

[21]  F. Budak,et al.  Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants. , 2012, European cytokine network.

[22]  R. Lorenz,et al.  Role of Postnatal Acquisition of the Intestinal Microbiome in the Early Development of Immune Function , 2010, Journal of pediatric gastroenterology and nutrition.

[23]  E. Bancalari,et al.  Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. , 2003, Seminars in neonatology : SN.

[24]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.

[25]  J. Versalovic,et al.  Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review , 2019, The Journal of pediatrics.

[26]  B. Dorum,et al.  Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia. , 2017, The Turkish journal of pediatrics.

[27]  L. Monte,et al.  [Bronchopulmonary dysplasia]. , 2005, Jornal de pediatria.

[28]  F. Ghezzi,et al.  Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. , 1997, American journal of obstetrics and gynecology.